David Gryska
Direktor/Vorstandsmitglied bei FORTE BIOSCIENCES, INC.
Vermögen: 109 752 $ am 30.04.2024
Aktive Positionen von David Gryska
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
FORTE BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | 10.01.2023 | - |
Independent Dir/Board Member | 10.01.2023 | - | |
MIND MEDICINE (MINDMED) INC. | Direktor/Vorstandsmitglied | 21.06.2023 | - |
Independent Dir/Board Member | 21.06.2023 | - |
Karriereverlauf von David Gryska
Ehemalige bekannte Positionen von David Gryska
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SEAGEN INC. | Direktor/Vorstandsmitglied | 25.03.2005 | 14.12.2023 |
Independent Dir/Board Member | 25.03.2005 | 14.12.2023 | |
AERIE PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 12.09.2018 | 21.11.2022 |
Independent Dir/Board Member | 12.09.2018 | 21.11.2022 | |
GW PHARMACEUTICALS PLC | Direktor/Vorstandsmitglied | 10.09.2020 | 05.05.2021 |
PDL BIOPHARMA, INC. | Direktor/Vorstandsmitglied | 05.03.2014 | 31.12.2020 |
Independent Dir/Board Member | 05.03.2014 | 31.12.2020 | |
INCYTE CORPORATION | Finanzdirektor/CFO | 31.10.2014 | 31.12.2018 |
AERIE PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 01.01.2012 | 01.01.2015 |
HYPERION THERAPEUTICS INC | Direktor/Vorstandsmitglied | 09.11.2010 | 15.03.2014 |
Independent Dir/Board Member | 09.11.2010 | 15.03.2014 | |
░░░░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░ ░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░░░░░░░ ░░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░ ░ ░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Ausbildung von David Gryska
Loyola University of Chicago | Undergraduate Degree |
Golden Gate University | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 13 |
Taiwan | 2 |
Vereinigtes Königreich | 2 |
Operativ
Director/Board Member | 13 |
Independent Dir/Board Member | 7 |
Director of Finance/CFO | 4 |
Sektoral
Health Technology | 11 |
Commercial Services | 3 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
INCYTE CORPORATION | Health Technology |
Private Unternehmen | 13 |
---|---|
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Health Technology |
Cardiac Pathways Corp.
Cardiac Pathways Corp. Medical SpecialtiesHealth Technology Cardiac Pathways Corp. designs, develops and manufactures cardiac diagnosis systems. Its products consist principally of systems for performing ablation treatment and for diagnostic mapping. Cardiac Pathways is located in Sunnyvale, CA. | Health Technology |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Commercial Services |
CoTherix, Inc.
CoTherix, Inc. Pharmaceuticals: MajorHealth Technology CoTherix, Inc. develops therapeutic products. Its ventavis product is a nebulizer delivered therapy for pulmonary artery hypertension, which restricts blood flow to the lungs. CoTherix markets its products in the US, Europe, and Australia. The company was founded in February, 2000 by Donald J. Santel and Gerard Turino and is located in Brisbane, CA. | Health Technology |
Seagen Inc.
Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
Hyperion Therapeutics, Inc.
Hyperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Hyperion Therapeutics, Inc. developed and commercialized pharmaceutical products. The company was founded by Mark Blumling and Christopher Eugene Rivera on November 1, 2006 and headquartered in Brisbane, CA. | Health Technology |
Medpace, Inc.
Medpace, Inc. Miscellaneous Commercial ServicesCommercial Services Medpace, Inc. provides clinical research services to the pharmaceutical, biotech and medical industries. It offers clinical operations, medical writing, biometrics, regulatory affairs, quality assurance, imaging core lab medical device and risk based monitoring services. The company was founded by August James Troendle in July 1992 and is headquartered in Cincinnati, OH. | Commercial Services |
PDL BioPharma, Inc.
PDL BioPharma, Inc. BiotechnologyHealth Technology PDL BioPharma, Inc. engages in the business of developing innovative therapeutics and healthcare technologies. It operates under the Medical Devices and Income Generating Assets segments. The Medical Devices segment focuses on the sale and lease of the LENSAR laser system which includes equipment, patient interface devices, procedure licenses, training, installation, warranty, and maintenance agreements. The Income Generating Assets segment offers notes and other long-term receivables; royalty rights, hybrid notes, and royalty receivables; equity investments; and royalties from issued patents covering the humanization of antibodies. The company was founded by Cary L. Queen and Laurence Jay Korn in 1986 and is headquartered in Reno, NV. | Health Technology |
Aerie Pharmaceuticals, Inc.
Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on January 1, 2005 and is headquartered in Durham, NCForth Worth, TX. | Health Technology |
GW Pharmaceuticals Ltd.
GW Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology GW Pharmaceuticals Ltd. operates as an intermediate holding company and management company for investments in its subsidiaries. The company was founded by Geoffrey William Guy and Brian Whittle in 1998 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Forte Biosciences, Inc. | |
Mind Medicine (MindMed), Inc. |
- Börse
- Insiders
- David Gryska
- Erfahrung